Colonic Inflammation in Mice Is Improved by Cigarette Smoke through iNKT Cells Recruitment

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Montbarbon, Muriel ^a,b   Pichavant, Muriel ^a,c,d   Langlois, Audrey ^a,b   Erdual, Edmone ^a,b   Maggiotto, François ^a,b   Neut, Christel ^a,b   Mallevaey, Thierry ^e   Dharancy, Sébastien ^a,f   Dubuquoy, Laurent ^a,b   Trottein, François ^a,c,d   Cortot, Antoine ^a,b,f   Desreumaux, Pierre ^a,b,f   Gosset, Philippe ^a,c,d   Bertin, Benjamin ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE LILLE   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d INSERM U1019   (France)

^e UNIVERSITY OF TORONTO   (Canada)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CD45 ANTIGEN; CIGARETTE SMOKE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; MESSENGER RNA; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; CYTOKINE; DEXTRAN SULFATE; SMOKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; COLITIS; CONTROLLED STUDY; LEUKOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOKING; TH1 CELL; TH2 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CELL COUNT; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; LIVER; METABOLISM; NATURAL KILLER T CELL; SMOKE; TOBACCO;

ANIMALIA; MUS;

ANIMALS; CELL COUNT; COLITIS; CYTOKINES; DEXTRAN SULFATE; GENE EXPRESSION REGULATION; LIVER; MALE; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; SMOKE; TOBACCO;

EID: 84876741260     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062208     Document Type: Article

References (47)

1. Baumgart DC, Carding SR, (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-40.
2. Abraham C, Cho JH, (2009) Inflammatory bowel disease. N Engl J Med 361: 2066-78.
3. Khor B, Gardet A, Xavier RJ, (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307-17.
4. Cosnes J, (2004) Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 18: 481-96.
5. Birrenbach T, Bocker U, (2004) Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 10: 848-59.
6. Sopori M, (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-7.
7. Karban A, Eliakim R, (2007) Effect of smoking on inflammatory bowel disease: Is it disease or organ specific? World J Gastroenterol 13: 2150-2.
8. Verschuere S, De Smet R, Allais L, Cuvelier CA, (2012) The effect of smoking on intestinal inflammation: what can be learned from animal models? J Crohns Colitis 6: 1-12.
9. Galeazzi F, Blennerhassett PA, Qiu B, O'Byrne PM, Collins SM, (1999) Cigarette smoke aggravates experimental colitis in rats. Gastroenterology 117: 877-83.
10. Ko JK, Sham NF, Guo X, Cho CH, (2001) Beneficial intervention of experimental colitis by passive cigarette smoking through the modulation of cytokines in rats. J Investig Med 49: 21-9.
11. Ko JK, Cho CH, (2005) The diverse actions of nicotine and different extracted fractions from tobacco smoke against hapten-induced colitis in rats. Toxicol Sci 87: 285-95.
12. Bendelac A, Savage PB, Teyton L, (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336.
13. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L, (2008) CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 20: 358-68.
14. Berzins SP, Smyth MJ, Baxter AG, (2011) Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 11: 131-42.
15. van Dieren JM, van der Woude CJ, Kuipers EJ, Escher JC, Samsom JN, et al. (2007) Roles of CD1d-restricted NKT cells in the intestine. Inflamm Bowel Dis 13: 1146-52.
16. Middendorp S, Nieuwenhuis EE, (2009) NKT cells in mucosal immunity. Mucosal Immunol 2: 393-402.
17. Olszak T, An D, Zeissig S, Vera MP, Richter J, et al. (2012) Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336: 489-93.
18. Wingender G, Stepniak D, Krebs P, Lin L, McBride S, et al. (2012) Intestinal Microbes Affect Phenotypes and Functions of Invariant Natural Killer T Cells in Mice. Gastroenterology 143: 418-28.
19. Hogan AE, Corrigan MA, O'Reilly V, Gaoatswe G, O'Connell J, et al. (2011) Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responses. Clin Immunol 140: 229-35.
20. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, et al. (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114: 385-91.
21. Melgar S, Karlsson A, Michaelsson E, (2005) Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288: G1328-38.
22. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, et al. (1998) Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42: 470-6.
23. Wallace JL, McKnight W, Asfaha S, Liu DY, (1998) Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation. Am J Physiol 274: G802-8.
24. Wingender G, Kronenberg M, (2008) Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation. Am J Physiol Gastrointest Liver Physiol 294: G1-8.
25. Borgerding M, Klus H, (2005) Analysis of complex mixtures-cigarette smoke. Exp Toxicol Pathol 57Suppl 1: 43-73.
26. Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, et al. (2009) Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 4: e6073.
27. Fang K, Bruce M, Pattillo CB, Zhang S, Stone R 2nd, et al (2011) Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. Physiol Genomics 43: 43-56.
28. Saubermann LJ, Beck P, De Jong YP, Pitman RS, Ryan MS, et al. (2000) Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119: 119-28.
29. Ueno Y, Tanaka S, Sumii M, Miyake S, Tazuma S, et al. (2005) Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm Bowel Dis 11: 35-41.
30. Shibolet O, Kalish Y, Klein A, Alper R, Zolotarov L, et al. (2004) Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. J Leukoc Biol 75: 76-86.
31. van de Wal Y, Corazza N, Allez M, Mayer LF, Iijima H, et al. (2003) Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology 124: 1420-31.
32. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P, (2011) Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334: 101-5.
33. Monteleone I, MacDonald TT, Pallone F, Monteleone G, (2012) The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis. Curr Opin Gastroenterol 28: 310-3.
34. Arsenescu R, Arsenescu V, Zhong J, Nasser M, Melinte R, et al. (2011) Role of the xenobiotic receptor in inflammatory bowel disease. Inflamm Bowel Dis 17: 1149-62.
35. Takamura T, Harama D, Matsuoka S, Shimokawa N, Nakamura Y, et al. (2010) Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol Cell Biol 88: 685-9.
36. Furumatsu K, Nishiumi S, Kawano Y, Ooi M, Yoshie T, et al. (2011) A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig Dis Sci 56: 2532-44.
37. Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, et al. (2011) Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology;141: 237-48, 248 e1.
38. Benson JM, Shepherd DM, (2011) Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. Toxicol Sci 120: 68-78.
39. Singh NP, Singh UP, Singh B, Price RL, Nagarkatti M, et al. (2011) Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One 6: e23522.
40. Huang Z, Jiang Y, Yang Y, Shao J, Sun X, et al. (2012) 3,3′-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction. Mol Immunol 53: 335-344.
41. Muto H, Takizawa Y, (1989) Dioxins in cigarette smoke. Arch Environ Health 44: 171-4.
42. Lofroth G, Zebuhr Y, (1992) Polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) in mainstream and sidestream cigarette smoke. Bull Environ Contam Toxicol 48: 789-94.
43. Kasai A, Hiramatsu N, Hayakawa K, Yao J, Maeda S, et al. (2006) High levels of dioxin-like potential in cigarette smoke evidenced by in vitro and in vivo biosensing. Cancer Res 66: 7143-50.
44. Horras CJ, Lamb CL, King AL, Hanley JR, Mitchell KA (2012) Consequences of TCDD treatment on intra-hepatic lymphocytes during liver regeneration. J Immunotoxicol.
45. Hegde S, Jankowska-Gan E, Roenneburg DA, Torrealba J, Burlingham WJ, et al. (2009) Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells. J Leukoc Biol 86: 757-68.
46. De Santo C, Arscott R, Booth S, Karydis I, Jones M, et al. (2010) Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat Immunol. 11: 1039-46.
47. Simoni Y, Diana J, Ghazarian L, Beaudoin L, Lehuen A, (2013) Therapeutic manipulation of NKT cells in autoimmunity: Are we close to reality? Clinical and Experimental Immunology 171: 8-19.